UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Yasminelle28-tablet-SE-AJ-RA

Generated Narrative: RegulatedAuthorization Yasminelle28-tablet-SE-AJ-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/23086

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00023086,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2006-07-21

holder: Organization Bayer AB

Cases

-TypeDate[x]
*First Authorisation2006-07-21